[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:prmt5-gene":3},{"name":4,"total":5,"recruiting":5,"trials":6},"PRMT5 Gene",4,[7,15,21,28],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06914128","A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors",[11],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:19:08.862440Z","2026-07-05T05:32:16.701684Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT06137144","AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.",[11],"2026-08-26T02:16:31.714843Z","2026-05-05T02:43:28.704937Z",{"nct_id":22,"title":23,"phases":24,"status":12,"updated_at":26,"content_modified":27},"NCT07277413","A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors",[25],"Phase 1","2026-08-26T02:16:01.910993Z","2026-07-05T05:32:16.679197Z",{"nct_id":29,"title":30,"phases":31,"status":12,"updated_at":32,"content_modified":33},"NCT05732831","Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors",[11],"2026-08-26T02:18:40.612983Z","2026-05-05T02:43:27.947953Z"]